We back early-stage healthcare and life sciences startups with funding and the strategic muscle of a leading advisory firm, helping founders navigate growth, access, and commercialization from day one.
We back early-stage, AI-first companies transforming precision medicine by improving patient identification, accelerating access, and scaling personalized care.
In 2024, just 2% of U.S. VC funding went to all-woman founding teams. Source
We are women‑led and committed to closing the gap.
Fewer than 25% of U.S. pharma companies have scaled AI beyond pilot projects. Source
Where pharma hesitates, our startups move first.
Healthcare AI investment is growing at a 37% CAGR, projected to reach $188 B by 2030, driven heavily by U.S. innovation. Source
We are funding the startups leading life sciences’ AI revolution.
Hands-on strategic support: We don’t just invest, we help you pressure-test your roadmap, sharpen your GTM, and navigate critical milestones.
Built-in life sciences expertise: We know the science and the system. From clinical to commercial, we’ve guided companies through every phase.
Access that accelerates: Unlock our deep network of payers, providers, KOLs, and industry insiders to open doors faster.
Operators in your corner: Think of us as an extension of your team, ready to roll up our sleeves on hiring, partnerships, trials, and more.
Where capital meets consulting: As a strategy firm with a fund, we’re uniquely positioned to help you think bigger and execute smarter.
Our team combines industry veterans with deep life sciences expertise and strategic insight alongside emerging talent bringing solutions at the forefront of innovation. Together, we act as true thought partners, working closely with founders to tackle challenges and accelerate growth.
